Co-Diagnostics (CODX) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free CODX Stock Alerts $1.22 -0.04 (-3.17%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Co-Diagnostics Short Interest DataCurrent Short Volume453,000 sharesPrevious Short Volume496,500 sharesChange Vs. Previous Month-8.76%Dollar Volume Sold Short$534,540.00Short Interest Ratio / Days to Cover8.0Last Record DateApril 15, 2024Outstanding Shares31,260,000 sharesPercentage of Shares Shorted1.45%Today's Trading Volume34,937 sharesAverage Trading Volume62,943 sharesToday's Volume Vs. Average56% Short Selling Co-Diagnostics ? Sign up to receive the latest short interest report for Co-Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCODX Short Interest Over TimeCODX Days to Cover Over TimeCODX Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Co-Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024453,000 shares $534,540.00 -8.8%N/A8 $1.18 3/31/2024496,500 shares $556,080.00 +30.1%N/A7.5 $1.12 3/15/2024381,500 shares $408,205.00 +11.8%N/A4.2 $1.07 2/29/2024341,300 shares $385,669.00 -28.3%N/A3.7 $1.13 2/15/2024475,700 shares $551,812.00 +32.3%N/A4.7 $1.16 1/31/2024359,600 shares $449,500.00 -36.9%N/A3.3 $1.25 Get the Latest News and Ratings for CODX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Co-Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024570,000 shares $798,000.00 -9.8%N/A5.2 $1.40 12/31/2023632,000 shares $840,560.00 +27.3%N/A6.2 $1.33 12/15/2023496,400 shares $565,896.00 -25.0%N/A6 $1.14 11/30/2023661,900 shares $781,042.00 -0.7%N/A8.9 $1.18 11/15/2023666,600 shares $926,574.00 +36.2%N/A8.5 $1.39 10/31/2023489,400 shares $523,658.00 -30.1%N/A7.2 $1.07 10/15/2023699,600 shares $741,576.00 -1.0%N/A8.3 $1.06 9/30/2023706,600 shares $748,996.00 +21.5%N/A5.7 $1.06 9/15/2023581,400 shares $680,238.00 -27.4%N/A4.6 $1.17 8/31/2023800,500 shares $992,620.00 -0.1%N/A6.4 $1.24 8/15/2023801,100 shares $969,331.00 +7.1%N/A6.4 $1.21 7/31/2023748,300 shares $1.17 million -2.4%N/A5.9 $1.56 7/15/2023766,900 shares $1.04 million +13.6%N/A6.6 $1.35 6/30/2023675,200 shares $749,472.00 -3.8%N/A7.2 $1.11 6/15/2023701,800 shares $757,944.00 +17.2%N/A5.9 $1.08 5/31/2023598,800 shares $652,692.00 -17.2%N/A4.2 $1.09 5/15/2023723,400 shares $976,590.00 -13.0%N/A5.3 $1.35 4/30/2023831,400 shares $1.15 million -3.1%N/A6.4 $1.38 4/15/2023857,900 shares $1.34 million -19.8%N/A6 $1.56 3/31/20231,070,000 shares $1.58 million +2.9%N/A7.5 $1.48 3/15/20231,040,000 shares $3.03 million -20.6%N/A7.7 $2.91 2/28/20231,310,000 shares $3.79 million +12.9%N/A10.9 $2.89 2/15/20231,160,000 shares $3.35 million -25.6%N/A8.7 $2.89 1/31/20231,560,000 shares $5.05 million +21.9%N/A10.9 $3.24 1/15/20231,280,000 shares $3.80 million -3.8%N/A8.8 $2.97 12/30/20221,330,000 shares $3.35 million -7.0%N/A8.5 $2.52 12/15/20221,430,000 shares $3.58 million -21.0%N/A8.4 $2.50 11/30/20221,810,000 shares $5.45 million -25.5%N/A9.3 $3.01 11/15/20222,430,000 shares $8.94 million +3.4%N/A9.2 $3.68 10/31/20222,350,000 shares $8.15 million +15.8%N/A5.5 $3.47 10/15/20222,030,000 shares $6.31 million +8.6%N/A3.7 $3.11 9/30/20221,870,000 shares $6.00 million -19.7%N/A3 $3.21 9/15/20222,330,000 shares $7.55 million +1.8%N/A3.5 $3.24 8/31/20222,290,000 shares $7.74 million +9.1%N/A3.5 $3.38The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. CODX Short Interest - Frequently Asked Questions What is Co-Diagnostics' current short interest? Short interest is the volume of Co-Diagnostics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 453,000 shares of CODX short. Learn More on Co-Diagnostics' current short interest. What is a good short interest ratio for Co-Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CODX shares currently have a short interest ratio of 8.0. Learn More on Co-Diagnostics's short interest ratio. Which institutional investors are shorting Co-Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Co-Diagnostics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Co-Diagnostics' short interest increasing or decreasing? Co-Diagnostics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 453,000 shares, a drop of 8.8% from the previous total of 496,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Co-Diagnostics' short interest compare to its competitors? Here is how the short interest of companies compare to Co-Diagnostics: Carmell Co. (0.18%), Modular Medical, Inc. (0.68%), iCAD, Inc. (1.73%), LENSAR, Inc. (0.73%), SeaStar Medical Holding Co. (6.36%), Daxor Co. (0.62%), Beyond Air, Inc. (8.91%), Akili, Inc. (0.15%), Femasys Inc. (5.84%), DarioHealth Corp. (4.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Co-Diagnostics stock? Short selling CODX is an investing strategy that aims to generate trading profit from Co-Diagnostics as its price is falling. CODX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Co-Diagnostics? A short squeeze for Co-Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CODX, which in turn drives the price of the stock up even further. How often is Co-Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CODX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Carmell Short Interest Data Modular Medical Short Interest Data iCAD Short Interest Data LENSAR Short Interest Data SeaStar Medical Short Interest Data Daxor Short Interest Data Beyond Air Short Interest Data Akili Short Interest Data Femasys Short Interest Data DarioHealth Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CODX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society